4DMedical Limited(FDMDF)
USD --+0.00%
Reward56Moderate
Risk76High
📊75%Data
FDMDF
+0.0 · +0.00%
USD · PINK
4DMedical Limited | Healthcare
Profitless Growth
Market Cap:1.45Bn
ℹ️
Reward Rating
56
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
76
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on FDMDF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is 4DMedical Limited?

4DMedical Limited operates as a medical technology company in the United States and Australia.

FDMDF · Verdict

Solid reward · high risk

FDMDF's standout is growth; volatility and cash flow weigh on the picture.

Based on 88% data coverage

FDMDF · Verdict

What’s working & what to watch

Strengths 1

  • Growth76/100

    Rev +77.1% CAGR · earnings +6.9%

Watchouts 4

  • Volatility5/100

    Weak vs peers

  • Cash flow6/100

    -590% free-cash-flow margin

  • Profitability32/100

    -514% net margin · -44% ROE

  • Valuation41/100

    Below average

Model-based scoring. For information only — not financial advice.

What is 4DMedical Limited?

4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.45B.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with growth and momentum as the leading contributors. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.45B
P/E RatioN/A
Dividend YieldN/A
52 Week High3.1
52 Week Low0.1625
Last AnnualJune
IPO DateN/A
IncorporatedUSA
Shares Outstanding572M
No. of Employees124
IndustryMedical Devices
ExchangePINK
Beta2.777
CurrencyUSD · Reports in AUD